Back to search

Article

CERTL reduces C16 ceramide, amyloid-β levels and inflammation in a model of Alzheimer's disease

2021-01-11

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Dysregulation of ceramide and sphingomyelin levels have been suggested to contribute to the pathogenesis of Alzheimer’s disease (AD). Ceramide transfer proteins (CERTs) are ceramide carriers which are crucial for ceramide and sphingomyelin balance in cells. Extracellular forms of CERTs co-localize with amyloid-β (Aβ) plaques in AD brains. To date, the significan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
21bea0cc-45d9-534d-8600-fa6e094335ce
DOI
10.21203/rs.3.rs-42740/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CERTL reduces C16 ceramide, amyloid-β levels and inflammation in a model of Alzheimer's diseaseDOI 10.21203/rs.3.rs-42740/v3
Select a neighboring publication to make it the new centre.